Subscribe to the Magazine for free.
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Top Women's Health Lab Tests Throughout The Lifespan

Medically reviewed by 
Top Women's Health Lab Tests Throughout The Lifespan

Proactive women’s health monitoring is paramount for women across life stages. This helps with early detection and prevention of various women’s health issues. From adolescence to menopause and beyond, tailored lab testing contributes to preventive healthcare for women and personalized medicine. Lab tests offer insights into things like hormonal balances, genetic predispositions, and metabolic markers unique to each woman, enabling tailored interventions. Proactive monitoring and personalized testing empower women themselves to proactively navigate their health journey, enhancing overall well-being and longevity throughout life's phases.


Importance of Regular Lab Testing for Women

Lab tests in women’s health play a key role in the early detection, prevention, and management of various health conditions. From routine screenings like Pap smears for cervical cancer to lipid panels for heart health, lab tests enable timely interventions and help to lower morbidity and mortality rates. Additionally, specialized tests such as BRCA gene testing help identify genetic predispositions for breast and ovarian cancers, empowering women to make informed decisions about strategies for risk reduction strategies. For sexually active women, the Centers for Disease Control (CDC) recommends Human Immunodeficiency Virus (HIV) testing at least once between 13 and 64 years of age and for gonorrhea and chlamydia every year.    

Hormonal changes and health risks vary throughout a woman's lifespan. For example, during menopause, declining estrogen levels increase the risk of chronic conditions such as osteoporosis and cardiovascular disease, highlighting the importance of bone density scans and lipid profiles. Similarly, hormonal imbalances in conditions like polycystic ovary syndrome (PCOS) necessitate hormone level assessments for accurate diagnosis and management.

By monitoring hormone levels, biomarkers, and genetic predispositions through tailored lab testing, healthcare providers can offer personalized interventions and preventive strategies, promoting optimal health outcomes for women throughout their various stages of life. These tests are valuable tools for the proactive management of women's health, emphasizing the importance of early detection and personalized interventions in reducing the disease burden and improving quality of life.

Adolescent and Young Adult Years (18-30)

Women between 18 to 30 years of age should undergo lab tests that evaluate their nutritional status, and baseline health metrics, and address reproductive health screening. A Complete Blood Count (CBC) helps evaluate overall health and assess for conditions such as infections or anemia. The Human Papillomavirus (HPV) test screens for the risk of cervical cancer and is essential for sexually active women. Additionally, testing iron and vitamin D levels facilitates the identification of deficiencies common in this age group, impacting energy levels and bone health.  

Establishing a health baseline during this stage helps detect deviations later in life. Regular screening through pap smears and HPV testing allows for early detection of HPV and thereby reduces the risk of developing cervical cancer. Monitoring iron levels helps prevent iron deficiency anemia, which is especially relevant for women who are menstruating. Similarly, assessing vitamin D levels helps reduce the risk of bone disorders and supports overall immune function.

Establishing baseline health metrics empowers women and their healthcare providers to track changes over time, facilitating proactive healthcare management. By identifying deficiencies or significant changes earlier than later, women can implement dietary modifications, and lifestyle changes, or obtain medical treatments to address potential health risks and optimize well-being.

Childbearing Years (31-45)

During the childbearing years, 31 to 45 years of age, women should undergo essential lab tests to ensure good health and to set themselves up for a healthy pregnancy. During this age period, tests to address fertility concerns can be performed. Fertility assessments for women can be done using a fertility hormone panel, including tests for follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, and anti-Müllerian hormone (AMH). These tests provide insights into ovarian function and egg reserve as well as help identify hormonal imbalances or low ovarian reserve.

Genetic screenings become increasingly relevant during the childbearing years. Carrier screenings for genetic disorders like cystic fibrosis, sickle cell anemia, and thalassemia provide valuable information about the risk of passing on these conditions to the fetus/infant. Additionally, prenatal genetic testing, such as non-invasive prenatal testing (NIPT), and diagnostic procedures like chorionic villus sampling (CVS) and amniocentesis, can identify chromosomal abnormalities and genetic disorders in the developing fetus.

During pregnancy, prenatal screening tests play a vital role in ensuring a healthy pregnancy. Gestational diabetes screening is recommended to diagnose and manage diabetes during pregnancy, reducing the risk of complications for both the mother and the fetus. Group B Streptococcus (GBS) screening, done between 36 and 38 weeks gestation, is necessary to identify bacterial infections that may pose a risk during childbirth, allowing for early interventions and treatment. Other lab tests that should be performed during pregnancy include syphilis (RPR), HIV, and Hepatitis B and C

Perimenopause and Menopause Transition (46-60)

For women between 46 to 60 years of age, who are undergoing transition to perimenopause and menopause, it is important to have lab testing done to assess hormonal changes, bone health, and heart health.  Menopause hormone testing, including tests for estrogen, follicle-stimulating hormone (FSH), and luteinizing hormone (LH), helps evaluate hormonal fluctuations characteristic of this life stage. Bone density screening, typically done through a Dual-Energy X-ray Absorptiometry (DEXA) scan, assesses bone mineral density and identifies osteoporosis risk. Additionally, lipid profiles, measuring cholesterol levels, aid in assessing cardiovascular risk, which increases post-menopause with declining estrogen levels.

Managing menopausal symptoms and preventing osteoporosis are integral components of perimenopause and menopause care. Hormone replacement therapy (HRT) or non-hormonal medications can alleviate symptoms like hot flashes and mood changes. Lifestyle modifications, including regular exercise and a calcium-rich diet, support bone health and reduce osteoporosis risk. Furthermore, optimizing cardiovascular health through lifestyle changes like adopting a heart-healthy diet, maintaining a healthy weight, and regular exercise is essential. Smoking cessation and stress management also contribute to cardiovascular risk reduction during menopause.

Senior Years (60+)

For women, 60 years and older, essential lab tests focus on chronic disease prevention and management and maintaining a good quality of life. Monitoring thyroid function through lab tests like Thyroid Stimulating Hormone (TSH) is important in this stage of life. Thyroid disorders are more prevalent in older age and impact metabolism and energy levels. Diabetes screenings, particularly measuring HbA1c levels, help assess long-term blood sugar control and reduce the risk of diabetes-related complications. Additionally, testing for Vitamin B levels, such as B-12 and folate is essential as deficiencies can lead to anemia, cognitive decline, and neuropathy, which are more common in older adults.

Aging women’s health tests are imperative to maintain health and well-being. Regular mammograms are recommended for breast cancer screening, with the risk increasing with age. Colon cancer screenings, such as colonoscopy or fecal occult blood testing, aid in early detection and prevention of colorectal cancer, a leading cause of cancer-related deaths in older women. Bone density screenings remain crucial to assess osteoporosis risk and guide preventive measures to prevent fractures and maintain mobility. Screenings for cognitive function, such as the Mini-Mental State Examination (MMSE), can help detect early signs of dementia and cognitive decline, allowing for early interventions and support.

In conclusion, important lab tests for aging women aged 60 years and older include assessments for chronic disease management and screenings for conditions prevalent in this population. Regular monitoring of thyroid function, diabetes status, Vitamin B12, and folate levels, along with screenings for breast cancer, colon cancer, osteoporosis, and cognitive function, contribute to maintaining health, quality of life, and longevity in older women.

Beyond Routine Screenings: Advanced Tests

Beyond routine screening, advanced or condition-specific health tests may offer deeper insight into women’s health status. For example, genetic markers in women’s health can identify hereditary predispositions to diseases like breast and ovarian cancers. Other tests such as advanced cardiovascular risk panels, inflammation markers, and genetic testing may be needed to evaluate cardiovascular disease risk more comprehensively. Incorporating these tests into regular health assessments provides several potential benefits. Firstly, early detection of genetic predispositions allows for personalized risk assessment and tailored preventive strategies, such as increased surveillance or risk-reducing interventions. Secondly, advanced cardiovascular risk panels offer a more detailed understanding of individual risk factors, enabling targeted interventions to mitigate cardiovascular disease risk. Moreover, these tests empower women to take proactive steps toward optimizing their health and well-being.

Advanced screen functional medicine tests for women encompass a comprehensive array of diagnostic tools tailored to address the unique health needs of women. These tests provide details about the aspects of hormonal balance, metabolic function, and nutritional status, providing valuable insights into root causes. Tests measuring inflammation markers, oxidative stress levels, and gut microbiome composition offer crucial information about overall health and potential predispositions to chronic diseases. By integrating these advanced screening tests into women's healthcare, clinicians can formulate personalized treatment strategies aimed at optimizing health at every stage of life.

However, considerations regarding the cost, accessibility, and psychological impact of these tests should be taken into account. For example, genetic testing may uncover unexpected results or raise concerns about privacy and discrimination. Additionally, the interpretation of advanced cardiovascular risk panels requires careful consideration of an individual’s risk factors and may lead to unnecessary interventions if not interpreted properly.

In conclusion, advanced lab tests beyond routine screening offer valuable insights into women's health, including genetic markers and advanced cardiovascular risk panels. While incorporating these tests into regular health assessments can provide personalized insights and facilitate targeted interventions, careful consideration of potential benefits and considerations is essential to ensure ethical and effective utilization in clinical practice.

Integrating Lab Tests into Personalized Health Plans

Personalized health plans for women enhance a woman’s well-being. Each woman is unique and may need different tests at different stages of their life. Certain health conditions may require additional tests or a different frequency of testing. All women should communicate their health goals, risk factors, and health conditions to their healthcare providers, fostering open and transparent discussions about their health needs and expectations. Understanding the significance of lab test results and how they relate to individual health status empowers women to make informed decisions about their health and wellness strategies.

Regular lab test follow-ups and adjustment of health strategies based on findings are essential components of personalized health management. Women should schedule routine follow-up appointments with their healthcare providers to review lab results, assess progress, and discuss any changes in their health status. Adjustments to health strategies, including medications, lifestyle modifications, and preventive interventions, should be made collaboratively based on evolving lab findings and individual health needs.



Lab testing plays an important role in women's health across their lifespan by providing valuable insights into reproductive health, chronic disease detection and management, and overall well-being. From fertility assessments and prenatal screenings to monitoring hormonal changes during menopause, lab tests help identify risk factors, guide preventive measures, and tailor treatment plans. By advocating for proactive women's health care and actively participating in discussions about lab results, women can empower themselves to take charge of their health journey and better collaborate with their health care providers to develop a personalized health care plan that addresses their unique needs and concerns.

The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article


1. ACOG. (2022). Non-Invasive Prenatal Testing.

2. American Cancer Society. (2018). Cancer Screening Guidelines By Age.; American Cancer Society .

3. ACOG. (2017). Carrier Screening for Genetic Conditions.

4. American Cancer Society. (2023). Colorectal Cancer Guideline | How Often to Have Screening Tests.

5. American College of Obstetricians and Gynecologists. (n.d.). Polycystic Ovary Syndrome (PCOS).

6. American Diabetes Association. (n.d.). Gestational Diabetes | ADA.

7. Aranow, C. (2011). Vitamin D and the immune system. Journal of Investigative Medicine : The Official Publication of the American Federation for Clinical Research, 59(6), 881–886.

8. Balzer, D. (2023, May 31). What’s the best nonhormonal therapy for hot flashes? Experts release new menopause therapy guidelines. Mayo Clinic News Network.

9. Bhatla, N., & Singhal, S. (2020). Primary HPV Screening for Cervical Cancer. Best Practice & Research Clinical Obstetrics & Gynaecology, 65.

10. BostonHeart Diagnostics. (n.d.). Complete Blood Count by BostonHeart Diagnostics. Rupa Health. Retrieved February 3, 2024, from

11. CDC. (2023, January 30). Which STD Tests Should I Get? | Prevention | STDs | CDC.

12. Cheng, C.-H., Chen, L.-R., & Chen, K.-H. (2022). Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover. International Journal of Molecular Sciences, 23(3), 1376.

13. Christie, J. (2023a, January 19). An Integrative Medicine Approach to Perimenopause. Rupa Health.

14. Christie, J. (2023, January 31). The Pros and Cons of Hormone Replacement Therapy: An Integrative Medicine Approach. Rupa Health.

15. Cleveland Clinic. (n.d.-a). Anti-Mullerian Hormone (AMH) Test: Purpose, Levels & Results. Cleveland Clinic.

16. Cleveland Clinic. (n.d.). Estradiol tablets. Cleveland Clinic.

17. Cleveland Clinic. (2022). Luteinizing Hormone: Levels, Function & Testing. Cleveland Clinic.

18. Cleveland Clinic. (2022b, May 21). DNA Test - Genetic Testing Overview. Cleveland Clinic.

19. Cleveland Clinic. (2023, January 23). Follicle-stimulating Hormone (FSH): What It Is & Function. Cleveland Clinic.

20. Cloyd, J. (2023a, February 8). An Integrative Medicine Approach to Thalassemia: Diagnosis, Testing, and Treatment. Rupa Health.

21. Cloyd, J. (2023, February 14). An Integrative Medicine Approach to Sickle Cell Anemia Treatment. Rupa Health.

22. Cloyd, J. (2023c, June 13). A Functional Medicine Menopause Protocol: Comprehensive Testing, Nutrition, and Supplements. Rupa Health.

23. Cloyd, J. (2023d, July 14). A Functional Medicine Osteopenia Protocol: Testing, Nutrition, and Specialized Supplements. Rupa Health.

24. Cloyd, J. (2024, January 17). HbA1c Testing: A Crucial Tool for Diabetes Management in Functional Medicine. Rupa Health.

25. Comprehensive Female Panel by Access Med Labs. (n.d.). Rupa Health. Retrieved February 3, 2024, from

26. Diab, N., Daya, N. R., Juraschek, S. P., Martin, S. S., McEvoy, J. W., Schultheiß, U. T., Köttgen, A., & Selvin, E. (2019). Prevalence and Risk Factors of Thyroid Dysfunction in Older Adults in the Community. Scientific Reports, 9(1).

27. Fernandez-Jimenez, M. C., Moreno, G., Wright, I., Shih, P.-C., Vaquero, M. P., & Remacha, A. F. (2020). Iron Deficiency in Menstruating Adult Women: Much More than Anemia. Women’s Health Reports, 1(1), 26–35.

28. Genova Diagnostics. (n.d.-a). Microbiomix by Genova Diagnostics. Rupa Health. Retrieved February 6, 2024, from

29. Genova Diagnostics. (n.d.). Oxidative Stress 2.0 Urine by Genova Diagnostics. Rupa Health. Retrieved February 6, 2024, from

30. Group B Strep and Pregnancy. (n.d.).

31. International Osteoporosis Foundation. (n.d.). About | International Osteoporosis Foundation.

32. Henein, M. Y., Vancheri, S., Longo, G., & Vancheri, F. (2022). The Role of Inflammation in Cardiovascular Disease. International Journal of Molecular Sciences, 23(21), 12906.

33. Henry, E. (n.d.). A Functional Medicine Approach to Thyroid Hormone Labs.

34. K-E, P. (2011). The following American Heart Association councils were also cosponsors: Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Basic Cardiovascular Sciences; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council for High Blood Pressure Research; Council on the Kidney in Cardiovascular Disease; Council on Nutrition. J.F.), American Academy of Family Physicians (T.J.), 1404–1423.

35. Jin, J. (2020). Screening for Cognitive Impairment in Older Adults. JAMA, 323(8), 800.

36. Joly, Y., & Dalpe, G. (2022). Genetic discrimination still casts a large shadow in 2022. European Journal of Human Genetics, 30(12), 1320–1322.

37. Keats, A. (n.d.). The Facts on Breast Cancer: Mammograms, Estrogen, and Prevention with Dr. Aminah Keats. Rupa Health. Retrieved February 4, 2024, from

38. Mayo Clinic. (n.d.). Pap smear - Mayo Clinic. Retrieved February 4, 2024, from

39. National Cancer Institute. (2021, March 5). Age and Cancer Risk. National Cancer Institute;

40. National Institutes of Health. (2023). Vitamin D.

41. Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., Rifai, N., Smith, S. C., Taubert, K., Tracy, R. P., Vinicor, F., Centers for Disease Control and Prevention, & American Heart Association. (2003). Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107(3), 499–511.

42. Prabakaran, S., Schwartz, A., & Lundberg, G. (2021). Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use. Therapeutic Advances in Endocrinology and Metabolism, 12, 204201882110139.

43. Preston, J. (2023a, March 15). An Integrative Medicine Approach to Managing Menopause Symptoms. Rupa Health.

44. Preston, J. (2023, July 25). An Integrative Approach to Prenatal Care: Complementing Conventional Care With Lab Testing, Nutrition, and Other Helpful Therapies. Rupa Health.

45. Rupa Health. (n.d.-a). Basic Laboratory Markers Testing. Rupa Health.

46. Rupa Health. (n.d.). Female Health Testing. Rupa Health. Retrieved February 3, 2024, from

47. Rupa Health. (n.d.-b). Vitamin D (25OH D2 & D3) by Doctor’s Data. Rupa Health. Retrieved February 3, 2024, from

48. Sharma, K. P., Grosse, S. D., Maciosek, M. V., Joseph, D., Roy, K., Richardson, L. C., & Jaffe, H. (2020). Preventing Breast, Cervical, and Colorectal Cancer Deaths: Assessing the Impact of Increased Screening. Preventing Chronic Disease, 17.

49. Santoro, N., Epperson, C. N., & Mathews, S. B. (2020). Menopausal Symptoms and Their Management. Endocrinology and Metabolism Clinics of North America, 44(3), 497–515.

50. Vibrant America. (n.d.). Inflammation Panel by Vibrant America. Rupa Health. Retrieved February 6, 2024, from

51. Yoshimura, H. (2023, August 15). A Comprehensive and Integrative Approach to Cystic Fibrosis. Rupa Health.

52. Young, L. M., Pipingas, A., White, D. J., Gauci, S., & Scholey, A. (2019). A Systematic Review and Meta-Analysis of B Vitamin Supplementation on Depressive Symptoms, Anxiety, and Stress: Effects on Healthy and “At-Risk” Individuals. Nutrients, 11(9), 2232.

Subscribe to the Magazine for free. to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.